.jpg?w=340&itok=gy9YTjEJ "EPR in healthcare news."){kind=icon}
.jpg?w=340&itok=lIHtTsIe "EPR in healthcare news."){kind=icon}
From MS to NMOSD to early Alzheimer's disease, neurologic mAbs are delivering proven clinical benefit. But as efficacy becomes less of a differentiator, what determines whether these therapies reach patients? In this art...
ICON experts frequently author or contribute to industry trade press.
Filter media
Filter media articles by either clicking within the ‘Category’ drop-down list, or begin typing which will automatically match to the nearest available category. Note - not all categories will display results if selecting a particular year.
-
How Global Capability Centers are Shaping the Future of Biometrics
In this interview with India Pharma Outlook, Nagalakshmi Shetty discusses India's emergence as a hub for Global Capability Centres (GCCs), emphasising GCCs' evolution from cost-saving units to innovation-driven strategic centres for global businesses.
-
5f84.jpg "EPR in healthcare news.")
The move to greener clinical development
Sustainability requires a layered approach that balances operational feasibility and with greener practices. Sean Morgan, Director of Clinical Supplies Management, discusses how ICON is tackling issues like kit waste, carbon emissions and ethical supply chains.
-
US Pharma and Biotech Summit 2024: Evolving clinical research
In this news article, Applied Clinical Trials reports on ICON CEO Steve Cutler’s discussion at the FT US Pharma and Biotech Summit. Topics addressed included the evolution of the CRO and sponsor relationship, the potential of AI in the clinical development space, and how ICON is helping customers build strong portfolios.
-
A pandemic-era staffing crunch in clinical trials is easing, but trouble spots remain
In an interview with PharmaVoice, Helen Yeardley, SVP, Global Clinical Operations outlines how the hiring landscape for CRAs has improved markedly, and the ongoing importance of attracting new candidates and providing training.
-
The CRA of the future: From ‘road warrior’ to site ‘owner’
In this article from Applied Clinical Trials, Helen Yeardley, SVP, Global Clinical Operations explores how the role of the CRA is rapidly evolving in response to changes in clinical trials. She outlines how the industry can invest in CRA talent and apply new thinking to critical areas, including site-performance management, risk management, remote monitoring, and remote data collection.
-
Shaking it up: The partnership paradigm in clinical research
Jeff James, Executive Vice President, Alliance Management, explores how outsourcing methodologies between large pharmaceutical companies and CROs have rapidly evolved across the healthcare and clinical research landscape.
Read the article on page 13 of the December issue of PharmaTimes.
-
Harmonising outsourcing to keep clinical trials on track
In this article in Applied Clinical Trials, Debbie Gilmore, Vice President, Strategic Alliance Management outlines how strategic partnerships and partnership-driven approaches to outsourcing can be used to navigate an increasingly complex clinical research landscape.
-
Modern partnerships with CROs
In this article in Contract Pharma, ICON SMEs share insight on strategic and blended outsourcing models and trends in today’s market.
-
fb14.jpg "EPR in healthcare news.")
Considerations for safety data migration methods
In this article, Graeme Bones, Director of Pharmacovigilance, explains how to handle the different types of data migration methods and how companies can select the optimum approach to ensure data integrity is maintained.
-
Clinical Data Management
In this article, Michael Phillips, discusses the ways in which machine learning can replace or augment traditional data review approaches while maintaining a risk-based, patient-centric approach and delivering higher quality outcomes with less human error.
